These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 2499251)
61. Efficacy of linezolid plus rifampin in an experimental model of methicillin-susceptible Staphylococcus aureus endocarditis. Dailey CF; Pagano PJ; Buchanan LV; Paquette JA; Haas JV; Gibson JK Antimicrob Agents Chemother; 2003 Aug; 47(8):2655-8. PubMed ID: 12878535 [TBL] [Abstract][Full Text] [Related]
62. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits. Chambers HF; Kartalija M; Sande M J Infect Dis; 1995 Apr; 171(4):897-902. PubMed ID: 7706817 [TBL] [Abstract][Full Text] [Related]
63. In-vitro susceptibility of staphylococci to fleroxacin in comparison with six other quinolones. Pohlod DJ; Saravolatz LD; Somerville MM J Antimicrob Chemother; 1988 Oct; 22 Suppl D():35-41. PubMed ID: 3144547 [TBL] [Abstract][Full Text] [Related]
64. In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible staphylococci. Fung-Tomc JC; Clark J; Minassian B; Pucci M; Tsai YH; Gradelski E; Lamb L; Medina I; Huczko E; Kolek B; Chaniewski S; Ferraro C; Washo T; Bonner DP Antimicrob Agents Chemother; 2002 Apr; 46(4):971-6. PubMed ID: 11897577 [TBL] [Abstract][Full Text] [Related]
68. In vivo efficacy of continuous infusion versus intermittent dosing of linezolid compared to vancomycin in a methicillin-resistant Staphylococcus aureus rabbit endocarditis model. Jacqueline C; Batard E; Perez L; Boutoille D; Hamel A; Caillon J; Kergueris MF; Potel G; Bugnon D Antimicrob Agents Chemother; 2002 Dec; 46(12):3706-11. PubMed ID: 12435665 [TBL] [Abstract][Full Text] [Related]
69. Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis. Hidalgo-Tenorio C; Gálvez J; Martínez-Marcos FJ; Plata-Ciezar A; De La Torre-Lima J; López-Cortés LE; Noureddine M; Reguera JM; Vinuesa D; García MV; Ojeda G; Luque R; Lomas JM; Lepe JA; de Alarcón A BMC Infect Dis; 2020 Feb; 20(1):160. PubMed ID: 32085732 [TBL] [Abstract][Full Text] [Related]
70. Comparison of the effectiveness of various antibiotics in the treatment of methicillin-susceptible Staphylococcus aureus experimental infective endocarditis. Apellaniz G; Valdés M; Perez R; Martin F; Soria F; Garcia A; Gòmez J; Vicente T J Chemother; 1991 Apr; 3(2):91-7. PubMed ID: 1875239 [TBL] [Abstract][Full Text] [Related]
71. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone. Siaperas P; Pefanis A; Iliopoulos D; Katsarolis I; Kyroudi-Voulgari A; Donta I; Karayiannakos P; Giamarellou H Antimicrob Agents Chemother; 2001 Dec; 45(12):3531-7. PubMed ID: 11709335 [TBL] [Abstract][Full Text] [Related]
72. Efficacy of cefepime in a Staphylococcus aureus endocarditis rat model. Lamb LM; Hibbard JR; Desiderio JV; Tsai YH J Antimicrob Chemother; 1993 Nov; 32 Suppl B():95-101. PubMed ID: 8150772 [TBL] [Abstract][Full Text] [Related]
74. Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest. Moreillon P; Bizzini A; Giddey M; Vouillamoz J; Entenza JM J Antimicrob Chemother; 2012 Mar; 67(3):652-60. PubMed ID: 22167243 [TBL] [Abstract][Full Text] [Related]
75. In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis. Boucher HW; Thauvin-Eliopoulos C; Loebenberg D; Eliopoulos GM Antimicrob Agents Chemother; 2001 Jan; 45(1):208-11. PubMed ID: 11120967 [TBL] [Abstract][Full Text] [Related]
76. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci. Ramos MC; Ing M; Kim E; Witt MD; Bayer AS Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887 [TBL] [Abstract][Full Text] [Related]
77. Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis. Galetto DW; Boscia JA; Kobasa WD; Kaye D J Infect Dis; 1986 Jul; 154(1):69-75. PubMed ID: 2940303 [TBL] [Abstract][Full Text] [Related]
78. Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis. de Górgolas M; Avilés P; Verdejo C; Fernández Guerrero ML Antimicrob Agents Chemother; 1995 Apr; 39(4):953-7. PubMed ID: 7786002 [TBL] [Abstract][Full Text] [Related]
79. Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin. Voorn GP; Kuyvenhoven J; Goessens WH; Schmal-Bauer WC; Broeders PH; Thompson J; Michel MF Antimicrob Agents Chemother; 1994 Mar; 38(3):487-93. PubMed ID: 8203842 [TBL] [Abstract][Full Text] [Related]
80. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. Chuard C; Lucet JC; Rohner P; Herrmann M; Auckenthaler R; Waldvogel FA; Lew DP J Infect Dis; 1991 Jun; 163(6):1369-73. PubMed ID: 1903801 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]